Skip to main content
Log in

Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: Effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen

  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

We performed an open, between patients, placebo controlled study in order to evaluate the effect of the treatment with the non steroidal anti inflammatory drugs indomethacin, diclofenac and naproxen on the concentrations of the cytokines IL-1β and IL-6 and of the neuropeptide substance P in plasma and synovial fluid of 24 rheumatoid arthritis patients. All patients had high synovial fluid cytokine and substance P levels, and high plasma cytokine levels at the beginning of the study. The treatment with the non steroidal anti inflammatory drugs significantly decreased both plasma and synovial fluid IL-6 and synovial fluid substance P in comparison to placebo, but did not affect IL-1β concentrations. This effect can participate in the therapeutic effect of non steroidal anti inflammatory drugs in rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brennan FM. Role of cytokines in experimental arthritis. Clin Exp Immunol 1994;97:1–3.

    Google Scholar 

  2. Arendt WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305–13.

    PubMed  Google Scholar 

  3. Eastgate JA, Wood NC, Di Giovine FS, Symons JA, Grinlinton F, Duff G. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988;ii:706–9.

    Google Scholar 

  4. Swaak AJ, Van Roojan Nieuwenhuis E, Aarden LA. Interleukin-6 in synovial fluid and serum of patients with rheumatic disease. Scand J Rheumatol 1988;17:469–74.

    PubMed  Google Scholar 

  5. Wood NC, Symons JA, Dickens E, Duff GW. In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 1992;87:183–9.

    PubMed  Google Scholar 

  6. Dayer JM, Rochemonteix B, Burrus B, Demczuck S, Dinarello C. Human recombinant IL-1 stimulates collagenases and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645–8.

    PubMed  Google Scholar 

  7. Levine JD, Clarck R, Devor M, Helms C, Moskowitz MA, Basbaum AI. Intraneural SP contributes to the severity of experimental arthritis. Science 1984;226:547–9.

    PubMed  Google Scholar 

  8. Marshall MW, Chiu B, Imman RD. Substance P and arthritis: analysis of plasma and SF levels. Arthritis Rheum 1990;33:87–90.

    PubMed  Google Scholar 

  9. Lotz M, Vaughan J, Carson D. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218–21.

    PubMed  Google Scholar 

  10. Arnett FC. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.

    PubMed  Google Scholar 

  11. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659–62.

    Google Scholar 

  12. Kellgren JH, Lawrence JS. Radiological assessment of rheumatoid arthritis. Ann Rheum Dis 1957;16:485–93.

    PubMed  Google Scholar 

  13. Pezzoli G, Panerai AE, Di Giulio AM, Londo A, Passerini D, Carenzi A. Methionine Enkephalin, Substance P, and homovanillic acid in the CSF of Parkinsonian patients. Neurology 1984;34:516–8.

    PubMed  Google Scholar 

  14. Panerai AE, Sacerdote P, Brini A, Bianchi M, Mantegazza P. Central nervous system neuropeptides after peripheral nerve deafferentation. Peptides 1988;9:319–24.

    PubMed  Google Scholar 

  15. Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, et al. IL-6/IFNβ2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. J Immunol 1989;143:2153–9.

    PubMed  Google Scholar 

  16. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan A, Dieppe PA. Synovial fluid concentration of five different cytokines in rheumatic diseases. Annals Rheum Dis 1990;49:676–81.

    Google Scholar 

  17. Bertazzolo N, Punzi L, Stefani MP, Cesaro G, Pianon M, Finco B, et al Interrelationship between interleukin-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 1994;41:90–2.

    PubMed  Google Scholar 

  18. Fontana A, Ihrie EJ, Dinarello CA, Cohen PI. Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982;2:49–53.

    PubMed  Google Scholar 

  19. Wood DD, Ihrie EJ, Dinarello CA, Cohen PI. Isolation of an interleukin-1 like factor from human joint effusion. Arthritis Rheum 1983;26:975–83.

    PubMed  Google Scholar 

  20. Komatsu H, Yaju H, Chiba K, Okumoto T. Inhibition by cyclo-oxygenase inhibitors of interleukin-6 production by human peripheral blood mononuclear cells. Int J Immunopharmacol 1991;13:1137–46.

    PubMed  Google Scholar 

  21. Gonzalez E, de la Cruz C, de Nicolas R, Egido G. Long term effect of NSAIDs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994;41:171–8.

    PubMed  Google Scholar 

  22. Endres S, Cannon JG, Ghorbani R, Dempsey RA, Sisson SD, Lonnemann GL, et al. In vitro production of IL-1β, IL-1α and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989;19:2327–33.

    PubMed  Google Scholar 

  23. Utsunomiya I, Nagai S, Ohishi S. Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin induced rat pleurisy. Eur J Pharmacol 1994;252:213–8.

    PubMed  Google Scholar 

  24. Sipe DJ, Cartle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. J Immunol 1992;148:480–4.

    PubMed  Google Scholar 

  25. Bahl AL, Dale MM, Foreman JC. The effect of non-steroidal anti-inflammatory drugs on the accumulation and release of IL-1-like activity by peritoneal macrophages from the mouse. Br J Pharmacol 1994;113:809–14.

    PubMed  Google Scholar 

  26. Abramson SB, Cherksey B, Gude D, Leszczynska-Piziak J, Philips M, Blau L, et al. Non steroidal antiinflammatory drugs exerts differential effects on neutrophil function and plasma viscosity. Inflammation 1990;14:11–30.

    PubMed  Google Scholar 

  27. Loctelli L, Sacerdote P, Mantegazza P, Panerai AE. Effect of ibuprofen and diclofenac on the chemotaxis induced by SP an TGF-beta on human monocytes and polymorphonuclear cells. Int J Immunopharmac 1993;15:833–8.

    Google Scholar 

  28. Sacerdote P, Monza G, Mantegazza P, Panerai AE. Diclofenac and pirprofen modify pituitary and hypothalamic betaendorphin concentrations. Pharmacol Res Comm 1985;17:679–84.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sacerdote, P., Carrabba, M., Galante, A. et al. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: Effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. Inflamm Res 44, 486–490 (1995). https://doi.org/10.1007/BF01837915

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01837915

Key words

Navigation